BDBM50202043 3-(4-((1-(4-cyclopropylidenecyclohexyl)-3-(4-(trifluoromethoxy)phenyl)ureido)methyl)benzamido)propanoic acid::CHEMBL220184

SMILES [#8]-[#6](=O)-[#6]-[#6]-[#7]-[#6](=O)-c1ccc(-[#6]-[#7](-[#6]-2-[#6]-[#6]\[#6](-[#6]-[#6]-2)=[#6]-2/[#6]-[#6]-2)-[#6](=O)-[#7]-c2ccc(-[#8]C(F)(F)F)cc2)cc1

InChI Key InChIKey=GWQKEFLPOJJJHI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50202043   

TargetGlucagon receptor(Human)
Novo Nordisk

Curated by ChEMBL
LigandPNGBDBM50202043(3-(4-((1-(4-cyclopropylidenecyclohexyl)-3-(4-(trif...)
Affinity DataIC50: 571nMAssay Description:Inhibition of human cloned glucagon receptor expressed in BHK cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed